Report - Regulatory Considerations on Pharmaceutical Solids ...€¦ · Polymorphs/Salts and Co -Crystals Andre S. Raw, Ph.D Director- Division of Chemistry I . FDA-CDER-Office of Generic

Please pass captcha verification before submit form